BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou K, Zhao J, Qi L, He Y, Xu J, Dai M. Kinesin Family Member C1 (KIFC1) Accelerates Proliferation and Invasion of Endometrial Cancer Cells Through Modulating the PI3K/AKT Signaling Pathway. Technol Cancer Res Treat 2020;19:1533033820964217. [PMID: 33034273 DOI: 10.1177/1533033820964217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Sharma N, Setiawan D, Hamelberg D, Narayan R, Aneja R. Computational benchmarking of putative KIFC1 inhibitors. Medicinal Research Reviews. [DOI: 10.1002/med.21926] [Reference Citation Analysis]
2 Khan MKA, Ahmad S, Rabbani G, Shahab U, Khan MS. Target-based virtual screening, computational multiscoring docking and molecular dynamics simulation of small molecules as promising drug candidate affecting kinesin-like protein KIFC1. Cell Biochem Funct 2022. [PMID: 35758564 DOI: 10.1002/cbf.3707] [Reference Citation Analysis]
3 Zhou K, Lin J, Dai M, He Y, Xu J, Lin Q. KIFC1 promotes aerobic glycolysis in endometrial cancer cells by regulating the c-myc pathway. J Bioenerg Biomembr 2021;53:703-13. [PMID: 34729671 DOI: 10.1007/s10863-021-09924-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]